LETTER
Arora, V.; Wongvipat, J.; Smith-Jones, P. M.; Yoo, D.;
Synthesis and Reactions of Dihydrothiouracils
2361
MS (APCI): m/z [M + H]+ calcd for C10H9ClN2OS: 241.02;
found: 241.13. 1H NMR (400 MHz, DMSO-d6): δ = 2.81–
2.85 (m, 2 H), 3.47–3.51 (m, 2 H), 7.16 (d, J = 8.4 Hz, 2 H),
7.43 (d, J = 8.4 Hz, 2 H), 10.01 (br s, 1 H). 13C NMR (100
MHz, DMSO-d6): δ = 30.96, 37.89, 128.80, 132.05, 132.63,
138.71, 167.76, 181.48.
3-(4-Chlorophenyl)-6-methyl-2-thioxotetrahydropyrim-
idin-4(1H)-one (4ab): Yield: 93%; white solid; mp 249–
251 °C. MS (APCI): m/z [M + H]+ calcd for C11H11ClN2OS:
255.03; found: 255.13. 1H NMR (400 MHz, DMSO-d6): δ =
1.26 (d, J = 6.4 Hz, 3 H), 2.66–2.73 (m, 1 H), 2.84–2.89 (m,
1 H), 3.86–3.87 (m, 1 H), 7.16 (d, J = 8.4 Hz, 2 H), 7.44 (d,
J = 8.4 Hz, 2 H), 10.06 (br s, 1 H). 13C NMR (100 MHz,
DMSO-d6): δ = 19.75, 38.10, 45.41, 128.85, 132.03, 132.68,
138.63, 167.57, 180.87.
Kwon, A.; Wasielewska, T.; Welsbie, D.; Chen, C. D.;
Higano, C. S.; Beer, T. M.; Hung, D. T.; Scher, H. I.; Jung,
M. E.; Sawyers, C. L. Science 2009, 324, 787. (c) Mehta, N.;
Risinger, C. A.; Soroko, F. E. J. Med. Chem. 1981, 24, 465.
(d) Wessels, F. L.; Schwan, T. J.; Pong, S. F. J. Pharm. Sci.
1980, 69, 1102. (e) Caldwell, A. G.; Harris, C. J.; Stepney,
R.; Wittaker, N. J. Chem. Soc., Perkin Trans. 1 1980, 495.
(5) (a) Elokdah, H.; Sulkowski, T. S.; Abou-Gharbia, M.;
Butera, J. A.; Chai, S.-Y.; McFarlane, G. R.; McKean, M.-
L.; Babiak, J. L.; Adelman, S. J.; Quinet, E. M. J. Med.
Chem. 2004, 47, 681. (b) Okawara, T.; Nakayama, K.;
Furukawa, M. Chem. Pharm. Bull. 1983, 31, 507.
(c) Hakkou, H.; Eynde, J. J. V.; Hamelin, J.; Bazureau, J. P.
Tetrahedron 2004, 60, 3745. (d) Soliman, R.; Habib, N. S.;
Ismail, K.; Moustafa, A.; Sarg, M. T.; Fanaki, N. H. Boll.
Chim. Farm. 2003, 142, 167. (e) Ojima, I.; Fuchikami, T.;
Fujita, M. T. US Patent 4581452, 1986. (f) Glasser, A. C.;
Doughty, R. M. J. Med. Chem. 1966, 9, 351.
(16) Energy calculations were performed using the Gaussian 03
program.
(17) The MESP surfaces were obtained by using the software
SPARTAN.
(6) Brouwer, G. W.; Felauer, E. E. US Patent 4927451, 1990.
(7) Kokotos, C. G.; Limnios, D.; Triggidou, D.; Trifonidou, M.;
Kokotos, G. Org. Biomol. Chem. 2011, 9, 3386.
(8) Raafat, S.; Allah-Hassan, F. M.; Mohamed, H. F. J. Pharm.
Sci. 1981, 70, 952.
(9) Delpiccolo, C. M. L.; Albericio, F.; Schiksnis, R. A.;
Michelotti, E. L. Tetrahedron 2007, 63, 8949.
(10) Johnson, T. B.; Livak, J. E. J. Am. Chem. Soc. 1936, 58, 299.
(11) Bizjak, M.; Oblak, S.; Tisler, M. J. Org. Chem. 1962, 27,
1343.
(18) General procedure for alkylation reaction: To a solution
of 3-aryl-2-thioxotetrahydropyrimidin-4(1H)-one (1.0
mmol) in DMF (5 mL) was added K2CO3 (1.6 mmol)
followed by alkyl halide (1.1 mmol). The reaction mixture
was stirred at room temperature and monitored by TLC.
After completion of the reaction, the solution was
concentrated under reduced pressure and the crude product
was precipitated from water. The product was purified by
column chromatography on silica gel (60–120 mesh;
hexane–EtOAc, 85:15).
(12) Prosen, A.; Stanvonik, B.; Tisler, M. J. Org. Chem. 1964, 29,
1623.
2-(Benzylthio)-3-(4-chlorophenyl)-5,6-
dihydropyrimidin-4(3H)-one (5a): Yield: 88%; white
solid; mp 180–182 °C. MS (APCI): m/z [M + H]+ calcd for
C17H15ClN2OS: 331.07; found: 331.12. 1H NMR (400 MHz,
DMSO-d6): δ = 2.69 (t, J = 7.3 Hz, 2 H), 3.86 (t, J = 7.3 Hz,
2 H), 4.12 (s, 2 H), 7.11–7.15 (m, 2 H), 7.20–7.27 (m, 5 H),
7.35–7.40 (m, 2 H). 13C NMR (100 MHz, DMSO-d6): δ =
30.96, 36.83, 44.56, 124.47, 128.54, 129.20, 129.43, 131.02,
133.93, 135.43, 136.04, 154.77, 168.87.
(13) (a) Kumar, V.; Nair, V. A. Tetrahedron Lett. 2010, 51, 966.
(b) Kumar, V.; Raghavaiah, P.; Mobin, S. M.; Nair, V. A.
Org. Biomol. Chem. 2010, 8, 4960. (c) Khatik, G. L.; Pal, A.;
Mobin, S. M.; Nair, V. A. Tetrahedron Lett. 2010, 51, 3654.
(d) Khatik, G. L.; Kaur, J.; Kumar, V.; Tikoo, K.;
Venugopalan, P.; Nair, V. A. Eur. J. Med. Chem. 2011, 46,
3291. (e) Chouhan, M.; Senwar, K. R.; Sharma, R.; Grover,
V.; Nair, V. A. Green Chem. 2011, 13, 2553. (f) Khatik, G.
L.; Khurana, R.; Kumar, V.; Nair, V. A. Synthesis 2011,
3123. (g) Sharma, R.; Chouhan, M.; Nair, V. A. Tetrahedron
Lett. 2010, 51, 2039. (h) Kumar, V.; Khatik, G. L.; Nair, V.
A. Synlett 2011, 2997. (i) Kumar, V.; Pal, A.; Khatik, G. L.;
Nair, V. A. Tetrahedron: Asymmetry 2012, 23, 434.
(j) Khatik, G. L.; Kaur, J.; Kumar, V.; Tikoo, K.; Nair, V. A.
Bioorg. Med. Chem. Lett. 2012, 22, 1912. (k) Khatik, G. L.;
Kumar, V.; Nair, V. A. Org. Lett. 2012, 14, 2442.
(19) General procedure for acylation reaction: A solution of
NaH (1.2 mmol) in THF (10 mL) was cooled to 0 °C and 3-
aryl-2-thioxotetrahydropyrimidin-4(1H)-one (1.0 mmol)
was added. The reaction mixture was stirred for 30 min, then
acyl chloride (1.1 mmol) was added. The reaction was
monitored by TLC and, after completion, quenched with
water and extracted into ethyl acetate. The organic layer was
dried and concentrated to provide a gummy compound,
which, upon purification by column chromatography on
silica gel (60–120 mesh; hexane–EtOAc, 85:15), afforded
the pure product.
(14) (a) Olimpieri, F.; Fustero, S.; Volonterio, A.; Zanda, M.
Synthesis 2010, 651. (b) Sundaram, G. S. M.; Venkatesh, C.;
Ila, H.; Junjappa, H. Synlett 2007, 251. (c) Kolasa, T.;
Miller, M. J. Tetrahedron 1989, 45, 3071.
(15) General procedure for the preparation of 3-aryl-2-
thioxotetrahydropyrimidin-4(1H)-ones: Aryl
1-Acetyl-3-(4-chlorophenyl)-2-
thioxotetrahydropyrimidin-4(1H)-one (6a): Yield: 70%;
light-yellow solid; mp 192–194 °C; MS (APCI): m/z [M +
H]+ calcd for C12H11ClN2O2S: 283.03; found: 282.88. 1H
NMR (400 MHz, DMSO-d6): δ = 2.70 (s, 3 H), 2.99 (t,
J = 6.6 Hz, 2 H), 4.23 (t, J = 6.6 Hz, 2 H), 7.07 (d, J =
8.3 Hz, 2 H), 7.45 (d, J = 8.5 Hz, 2 H). 13C NMR (100 MHz,
DMSO-d6): δ = 27.60, 33.19, 40.82, 129.69, 130.38, 134.78,
137.08, 166.90, 174.03, 182.58.
isothiocyanate (3.0 mmol) was dissolved in methanol (20
mL) and β-amino ester (3.0 mmol) was added, followed by
10 M KOH (2 mL). The reaction mixture was stirred at 20 °C
for 2 h. After completion of the reaction, the solution was
concentrated under reduced pressure and then neutralized by
1 M HCl until precipitation occurred. The product obtained
was filtered and dried to give the desired acid. The acid was
dissolved in acetonitrile (15 mL) and CDI (4.0 mmol) was
added. The reaction mixture was stirred for 20 min (progress
was monitored by TLC). Upon completion, the reaction
mixture was concentrated and the product was precipitated
in water, filtered, dried and recrystallized in methanol.
3-(4-Chlorophenyl)-2-thioxotetrahydropyrimidin-
4(1H)-one (4aa): Yield: 90%; white solid; mp 201–203 °C;
(20) General procedure for 1,4-addition reaction: A procedure
similar to the preparation of 3-aryl-2-(alkylthio)-5,6-
dihydropyrimidin-4(3H)-ones was adopted for the aza-
Michael reactions.
Methyl 3-[3-(4-chlorophenyl)-4-oxo-2-
thioxotetrahydropyrimidin-1(2H)-yl]propanoate (7a):
Yield: 70%; light-brown liquid. MS (APCI): m/z [M + H]+
calcd for C14H15ClN2O3S: 327.06; found: 327.03. 1H NMR
(400 MHz, DMSO-d6): δ = 2.82–2.84 (m, 4 H), 3.64 (s, 3 H),
© Georg Thieme Verlag Stuttgart · New York
Synlett 2012, 23, 2357–2362